_20240830155659_original_image_38.webp)
According to the Global Cancer Observatory (GLOBOCAN), in 2022, India recorded 1.41 million new cancer cases, placing it third globally after China and the United States of America
Read More_20240730163304_original_image_14.webp)
Patients treated with Nimotuzumab alongside concurrent radiotherapy and cisplatin showed a 10-year overall survival rate of 33.5 per cent, compared to 22.5 per cent for those who received only radiotherapy and cisplatin
Read More
As of 2024, the World Health Organization (WHO) estimates that over 19 million new cancer cases occur annually, with over 10 million cancer-related deaths
Read More
